Lier Chemical Co.,LTD. engages in the research and development, production, and sale of pesticide products in the People’s Republic of China and internationally. The company offers safe pesticides, such as chloropyridines, organophosphates, sulfonylureas, and substituted ureas. It also provides herbicides, including glufosinate-ammonium, diquat, flumioxazin, clodinafop propargyl, clopyralid, picloram, fluroxypyr-meptyl, triclopyr, amipyralid, pinoxaden, diquat, diuron, bensulfuron-methyl, linuron, pyrazosulfuron-ethyl, nicosulfuron, flufenacet, mefenacet, and quinclorac; fungicides, such as prothioconazole, azoxystrobin, epoxiconazole, iprodione, and difenoconazole; and insecticides comprising Chlorantraniliprole, chlorpyrifos, and pyriproxyfen, as well as active pharmaceutical ingredients. In addition, the company offers chemical intermediates, including 2-chloropyridine; 2,3-dichloropyridine; 2,5-dichloropyridine; 2,6-dichloropyridine; 2,3,4-trichloropyridine; 2,3,5-trichloropyridine; 2,3,6-trichloropyridine; nitrapyrin; pentafluoropyridine; 2,3,5,6-tetrachloro-4-methylsulfonylpyridine; 6-chloropyridine-2-carbonitrile; 3,6-difluoropyridine-2-carboxylic acid; 2,2'-bipyridine; 2-chloro-4'-fluoroacetophenone; 2-chloro-2',4'-difluoroacetophenone; and 2-fluoro-3-nitrobenzoic acid. Further, its intermediates comprise (E)-4-(dimethylamino)but-2-enoic acid hydrochloride; 4,4'-dichloro-[3,3']bipyridinyl; clopyralid-methyl; methyl 3,4,6-trichloropicolinate; 2,4,5-trichloropyridine; 7-fluoro-6-nitro-4-hydroxyquinazoline; N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine; 4-bromocrotonic acid; 4-N-(3-chloro-4-fluorophenyl)-7-[(3S)-oxolan-3-yl]oxyquinazoline-4,6-diamine; 2-amino-N-(2-chloro-6-methylphenyl)-1,3-thiazole-5-carboxamide; and 5-chloro-8-hydroxyquinoline. Lier Chemical Co.,LTD. was founded in 1993 and is headquartered in Mianyang, China.
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
The market has stayed flat over the 7 days. As for the longer term, the market has risen 16% in the past 12 months. Looking forward, earnings are forecast to grow by 27% annually. Market details ›